TG Therapeutics Inc (NAS:TGTX)
$ 16.48 -0.94 (-5.4%) Market Cap: 2.55 Bil Enterprise Value: 2.45 Bil PE Ratio: 74.91 PB Ratio: 15.91 GF Score: 75/100

TG Therapeutics, Inc. - Special Call Transcript

Apr 01, 2019 / 04:00PM GMT
Release Date Price: $8.09 (+0.62%)
Operator

Greetings, and welcome to the TG Therapeutics AACR Data Update Call. (Operator Instructions) As a reminder, this conference is being recorded.

I would now like to turn the conference over to your host, Michael S. Weiss, Chief Executive Officer in TG Therapeutics. Thank you. You may begin.

Michael S. Weiss
TG Therapeutics, Inc. - Executive Chairman, CEO & President

Thank you, Ena. Thanks, everyone, for joining us today. We're very excited about the news this morning and the presentation.

Before I get started, let me just mention that we may or will be making some forward-looking statements. And as usual, anyone who is interested, we do encourage you to look at our public disclosure documents and the risk factors available on the Internet.

So we've got a special guest today. The way this is going to work, Dr. Fowler is going to give the same presentation that he gave this morning for the press conference and the presentation he'll give this afternoon to the larger audience at AACR. So that's a very special treat we've arranged.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot